Cited by 244Cystic Fibrosis Research AdvancesBacterial biofilms and quorum sensingChronic Obstructive Pulmonary Disease (COPD) Research

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

A Novel Microbiota Stratification System Predicts Future Exacerbations in Bronchiectasis

Rogers, Geraint B., Zain, Nur Masirah M., Bruce, Kenneth D., Burr, Lucy D., Chen, Alice C., Rivett, Damian W., McGuckin, Michael A., Serisier, David J.·2014·Annals of the American Thoracic Society

DOI 10.1513/annalsats.201310-335oc

Open this paper in CoChat — free account

Abstract

RATIONALE: Although airway microbiota composition correlates with clinical measures in non-cystic fibrosis bronchiectasis, these data are unlikely to provide useful prognostic information at the individual patient level. A system enabling microbiota data to be applied clinically would represent a substantial translational advance. OBJECTIVES: This study aims to determine whether stratification of patients according to the predominant microbiota taxon can provide improved clinical insight compared with standard diagnostics. METHODS: The presence of bacterial respiratory pathogens was assessed in induced sputum from 107 adult patients by culture, quantitative PCR, and, in 96 samples, by ribosomal gene pyrosequencing. Prospective analysis was performed on samples from 42 of these patients. Microbiological data were correlated with concurrent clinical measures and subsequent outcomes. MEASUREMENTS AND MAIN RESULTS: Microbiota analysis defined three groups: Pseudomonas aeruginosa dominated (n = 26), Haemophilus influenzae dominated (n = 34), and other taxa dominated (n = 36). Patients with P. aeruginosa- and H. influenzae-dominated communities had significantly worse lung function, higher serum levels of C-reactive protein (CRP), and higher sputum levels of IL-8 and IL-1β. Predominance of P. aeruginosa, followed by Veillonella species, was the best predictor of future exacerbation frequency, with H. influenzae-dominated communities having significantly fewer episodes. Detection of P. aeruginosa was associated with poor lung function and exacerbation frequency, irrespective of analytical strategy. Quantitative PCR revealed significant correlations between H. influenzae levels and sputum IL-8, IL-1β, and serum CRP. Genus richness was negatively correlated with 24-hour sputum weight, age, serum CRP, sputum IL-1β, and IL-8. CONCLUSIONS: Stratification of patients with non-cystic fibrosis bronchiectasis on the basis of predominant bacterial taxa is more clinically informative than either conventional culture or quantitative PCR-based analysis. Further investigation is now required to assess the mechanistic basis of these associations.

Integrity signals

Registry

Crossref · 10.1513/annalsats.201310-335oc

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An Investigation into Causative Factors in Patients with Bronchiectasis
Pasteur, M. C., Helliwell, S. M., HOUGHTON, S. J., WEBB, S. C., Foweraker, J. E., Coulden, R. A., Flower, C. D. R., Bilton, D., & Keogan, M. T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9906120 · Cited by 681
Decade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention
Koenig, S. M., & Truwit, J. D. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-05 · Cited by 550
Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis
Martínez‐García, M. Á., Soler‐Cataluña, J. J., Perpiñá-Tordera, M., Román-Sánchez, P., & Soriano, J. B. (2007) · CHEST Journal · doi:10.1378/chest.07-0490 · Cited by 484
Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
Cox, M. J., Allgaier, M., Taylor, B., Baek, M. S., Huang, Y. J., Daly, R. A., Karaöz, U., Andersen, G. L., Brown, R., Fujimura, K. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011044 · Cited by 458
Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis
Serisier, D. J., Martin, M. L., McGuckin, M. A., Lourie, R., Chen, A. C. –., Brain, B., Biga, S., Schlebusch, S., Dash, P., & Bowler, S. (2013) · JAMA · doi:10.1001/jama.2013.2290 · Cited by 419
Self-citation
Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis
Chalmers, J. D., Smith, M. P., McHugh, B. J., Doherty, C., Govan, J. R. W., & Hill, A. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0487oc · Cited by 408
Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation
Tunney, M. M., Einarsson, G. G., Wei, L., Drain, M., Klem, E. R., Cardwell, C., Ennis, M., Boucher, R. C., Wolfgang, M. C., & Elborn, J. S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1937oc · Cited by 316
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities
Gast, C., Walker, A. W., Stressmann, F. A., Rogers, G. B., Scott, P., Daniels, T. W. V., Carroll, M. P., Parkhill, J., & Bruce, K. D. (2010) · The ISME Journal · doi:10.1038/ismej.2010.175 · Cited by 265
Self-citation
Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa
Evans, S. Y., Turner, S., Bosch, B., Cc, H., & Woodhead, M. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09081601 · Cited by 247

Show all 19 references

Research works printed but not linked: 1

Cole, 1986, Inflammation: a two-edged sword—the model of bronchiectasis, Eur J Respir Dis Suppl, 147, 6

Sorted by citations

Items 101–200 of 242

Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: C linical, physiological and sputum characteristics
Venning, V. L., Bartlett, J., & Jayaram, L. (2017) · Respirology · doi:10.1111/resp.13005 · Cited by 24
Multiple inflammasomes may regulate the interleukin-1-driven inflammation in protracted bacterial bronchitis
Chen, A. C. –., Tran, H. B., Xi, Y., Yerkovich, S. T., Baines, K. J., Pizzutto, S. J., Carroll, M. L., Robertson, A. A. B., Cooper, M. A., Schroder, K., et al. (2018) · ERJ Open Research · doi:10.1183/23120541.00130-2017 · Cited by 24
Self-citation
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study
Choate, R., Aksamit, T. R., Mannino, D. M., Addrizzo-Harris, D. J., BARKER, A. R., Basavaraj, A., Daley, C. L., Daniels, M. L. A., Eden, E., DiMango, A. M., et al. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106285 · Cited by 23
Bronchiectasis in the Last Five Years: New Developments
Khoo, J. K., Venning, V. L., Wong, C., & Jayaram, L. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5120115 · Cited by 23
Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis
Alcaraz-Serrano, V., Fernández‐Barat, L., Scioscia, G., Llorens, J., Gimeno‐Santos, E., Herrero‐Cortina, B., Vázquez, N., de la Bellacasa, J. P., Gabarrús, A., Amaro-Rodríguez, R., et al. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.06.012 · Cited by 23
Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
Huang, G., Hu, H., Zhang, Y., Zhu, Y., Liu, J., Tan, B., & Chen, T. (2019) · Journal of Cancer · doi:10.7150/jca.30669 · Cited by 23
Measuring airway clearance outcomes in bronchiectasis: a review
Franks, L. J., Walsh, J., Hall, K., & Morris, N. R. (2020) · European Respiratory Review · doi:10.1183/16000617.0161-2019 · Cited by 22
The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroids
Martin, M. J., Zain, N. M. M., Hearson, G., Rivett, D. W., Koller, G., Wooldridge, D. J., Rose, G., Gharbia, S. E., Forbes, B., Bruce, K. D., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244681 · Cited by 24
Self-citation
Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives
Sugianto, T. D., & Chan, H. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1078309 · Cited by 21
Update in Bronchiectasis 2014
Amalakuhan, B., Maselli, D. J., & Martínez‐García, M. Á. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0926up · Cited by 21
Altered community compositions of Proteobacteria in adults with bronchiectasis
Guan, W., Yuan, J.-J., Li, H., Gao, Y., Chen, C.-L., Huang, Y., Chen, R., & Zhong, N. (2018) · International Journal of COPD · doi:10.2147/copd.s159335 · Cited by 20
Respiratory Bacterial Microbiota and Individual Bacterial Variability in Lung Cancer and Bronchiectasis Patients
Ekanayake, A., Madegedara, D., Chandrasekharan, V., & Magana-Arachchi, D. (2019) · Indian Journal of Microbiology · doi:10.1007/s12088-019-00850-w · Cited by 21
Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan
Lin, C., Huang, H.-Y., Hsieh, M., Fang, Y., Lo, Y., Lin, S., Huang, Y., Yeh, C., Wang, C., & Lin, H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.868435 · Cited by 19
Profiling mycobacterial communities in pulmonary nontuberculous mycobacterial disease
Cowman, S. A., James, P. L., Wilson, R. C., Cookson, W., Moffatt, M. F., & Loebinger, M. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208018 · Cited by 19
Airway microbiota is associated with the severity of non‐CF bronchiectasis
Li, L., Zhang, J., Li, Z., Zhang, C., Bi, J., Zhou, J., Song, Y., & Shao, C. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13279 · Cited by 18
The Fungal and Bacterial Interface in the Respiratory Mycobiome with a Focus on Aspergillus spp.
Rozaliyani, A., Antariksa, B., Nurwidya, F., Zaini, J., Setianingrum, F., Hasan, F. N., Nugrahapraja, H., Yusva, H., Wibowo, H., Bowolaksono, A., et al. (2023) · Life · doi:10.3390/life13041017 · Cited by 19
Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis––experiences from recent clinical trials
Aller, S. P., Quittner, A. L., Salathe, M. A., & Schmid, A. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1503540 · Cited by 18
Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease
Cai, L., Gao, P., Wang, Z., Dai, C., Ye, N., İlkit, M., Xue, X., Xiao, J., & Chen, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988708 · Cited by 17
Bronchiectasis and cough: An old relationship in need of renewed attention
Aogáin, M. M., & Chotirmall, S. H. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.101812 · Cited by 16
Pseudomonas aeruginosa in Bronchiectasis
Fernández‐Barat, L., Alcaraz-Serrano, V., Amaro, R., & Torres, A. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1730921 · Cited by 16
Comparison of different conditions for DNA extraction in sputum - a pilot study
Oriano, M., Terranova, L., Teri, A., Sottotetti, S., Ruggiero, L., Tafuro, C., Marchisio, P., Gramegna, A., Amati, F., Nava, F., et al. (2019) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-018-0166-z · Cited by 16
The role of T-helper and T regulatory cells in driving neutrophilic and eosinophilic inflammation in bronchiectasis
Fouka, E., Lindén, A., & Bossios, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1598257 · Cited by 16
A multicenter prospective study of comprehensive metagenomic and transcriptomic signatures for predicting outcomes of patients with severe community-acquired pneumonia
Zhao, J., He, X., Min, J., Yao, R. S. Y., Chen, Y., Chen, Z., Huang, Y. X., Zhu, Z., Gong, Y., Xie, Y., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104790 · Cited by 15
Intermittent prophylactic antibiotics for bronchiectasis
Spencer, S., Donovan, T., Chalmers, J. D., Mathioudakis, A. G., McDonnell, M. J., Tsang, A., & Leadbetter, P. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013254.pub2 · Cited by 15
Introduction to Techniques and Methodologies for Characterizing the Human Respiratory Virome
Mitchell, A. B., & Glanville, A. R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8682-8_9 · Cited by 16
Haemophilus influenzae in bronchiectasis
Angelis, A. D., Marchello, M., Tramontano, A., Cicchetti, M., Nigro, M., Simonetta, E., Scarano, P., Polelli, V., Artuso, V. A., & Aliberti, S. (2025) · European Respiratory Review · doi:10.1183/16000617.0007-2025 · Cited by 14
The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection
Combs, M. P., Luth, J. E., Falkowski, N. R., Wheeler, D., Walker, N., Erb‐Downward, J. R., Wakeam, E., Sjoding, M. W., Dunlap, D. G., Admon, A. J., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202308-1326oc · Cited by 14
Hot topics and current controversies in non-cystic fibrosis bronchiectasis
Severiche-Bueno, D. F., Gamboa, E., Reyes, L. F., & Chotirmall, S. H. (2019) · Breathe · doi:10.1183/20734735.0261-2019 · Cited by 13
The Open Challenge of in vitro Modeling Complex and Multi-Microbial Communities in Three-Dimensional Niches
Oriano, M., Zorzetto, L., Guagliano, G., Bertoglio, F., van Uden, S., Visai, L., & Petrini, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.539319 · Cited by 13
Human airway and lung microbiome at the crossroad of health and disease (Review)
Raudoniūtė, J., Bironaitė, D., Bagdonas, E., Kulvinskienė, I., Jonaitytė, B., Danila, E., & Aldonytė, R. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11718 · Cited by 13
Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials
Lim, J. U., Hong, S. W., & Ko, J. (2019) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466619875930 · Cited by 13
Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients
Rønn, C. P., Kamstrup, P. T., Eklöf, J. V., Toennesen, L. L., Boel, J. B., Andersen, C. Ø., Dessau, R. B., Wilcke, J. T., Sivapalan, P., Ulrik, C. S., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02544-w · Cited by 12
Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium
Collie, D., Glendinning, L., Govan, J. R. W., Wright, S. H., Thornton, E. M., Tennant, P. A., Doherty, C. J., & McLachlan, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142097 · Cited by 15
Exacerbation of Bronchiectasis
Polverino, E., Rosales-Mayor, E., & Torres, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-61452-6_15 · Cited by 12
Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence
de la Rosa, D., Suárez-Cuartín, G., Golpe, R., Carro, L. M., & Martínez‐García, M. Á. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s318173 · Cited by 12
Dynamic Upper and Lower Airway Microbiotas in Paediatric Bronchiectasis Exacerbations: A Pilot Study
Broderick, D. T. J., Regtien, T., Ainsworth, A., Taylor, M. W., & Pillarisetti, N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.773496 · Cited by 11
Targeting respiratory microbiomes in COPD and bronchiectasis
Aogáin, M. M., Tiew, P. Y., Jaggi, T. K., Narayana, J. K., Singh, S., Hansbro, P. M., Segal, L. N., & Chotirmall, S. H. (2024) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2024.2355155 · Cited by 11
Clinical Impacts of Pseudomonas aeruginosa Isolation in Patients with Bronchiectasis: Findings from KMBARC Registry
Song, J. H., Sin, S., Kang, H.-R., Oh, Y., & Jeong, I. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175011 · Cited by 11
The contribution of respiratory microbiome analysis to a treatable traits model of care
Taylor, S., O’Farrell, H. E., Simpson, J. L., Yang, I. A., & Rogers, G. B. (2018) · Respirology · doi:10.1111/resp.13411 · Cited by 11
Self-citation
2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent Pseudomonas aeruginosa burden in adults with cystic fibrosis
Zain, N. M. M., Webb, K., Stewart, I. D., Halliday, N., Barrett, D. A., Nash, E. F., Whitehouse, J. L., Honeybourne, D., Smyth, A. R., Forrester, D. L., et al. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001420 · Cited by 11
Self-citation
Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis
O’Neill, K., Einarsson, G. G., Rowan, S., McIlreavey, L., Lee, A. J., Lawson, J., Lynch, T. B., Horsley, A. R., Bradley, J. M., Elborn, J. S., et al. (2019) · Respirology · doi:10.1111/resp.13653 · Cited by 11
Duration of Antibiotic Therapy in Non-cystic Fibrosis Bronchiectasis
Somayaji, R., & Goss, C. H. (2019) · Current Pulmonology Reports · doi:10.1007/s13665-019-00235-w · Cited by 11
Gender differences in clinical characteristics of patients with non‐cystic fibrosis bronchiectasis in different age groups in northern China
Zhou, Y., Wang, Y., He, S., Wang, W., Wang, X., Li, D., Chen, X., Feng, X., & Bu, X. (2023) · The Clinical Respiratory Journal · doi:10.1111/crj.13596 · Cited by 10
Sputum metagenomics of people with bronchiectasis
Rosenboom, I., Thavarasa, A., Richardson, H., Long, M. B., Wiehlmann, L., Davenport, C., Shoemark, A., Chalmers, J. D., & Tümmler, B. (2024) · ERJ Open Research · doi:10.1183/23120541.01008-2023 · Cited by 9
Exacerbations of bronchiectasis in adults
Chalmers, J. D., Redondo, M., & Ferri, S. (2016) · Community Acquired Infection · doi:10.4103/2225-6482.184910 · Cited by 9
Bronchiectasis
Moreno, B. R., Pou, C., Castañón, R. A., Erro, M., Sánchez, C., Manzano, C., Zamarrón, E., Suárez-Cuartín, G., & González, J. (2024) · Open Respiratory Archives · doi:10.1016/j.opresp.2024.100339 · Cited by 9
Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease
Jaat, F. G., Hasan, S. F., Perry, A., Cookson, S., Murali, S., Perry, J. D., Lanyon, C. V., Soyza, A. D., & Todryk, S. M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0811-2 · Cited by 9
A systematic review of lung clearance index in non-cystic fibrosis, non-primary ciliary dyskinesia bronchiectasis
Hine, C., Desai, M., Davies, J. C., Sapey, E., & Nagakumar, P. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106937 · Cited by 8
The lung microbiome
Rogers, G. B. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170043 · Cited by 8
Self-citation
Emerging drugs for bronchiectasis: an update
Chang, A. B., Marsh, R. L., Smith‐Vaughan, H., & Hoffman, L. R. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1021683 · Cited by 8
The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study
Masekela, R., Vosloo, S., Venter, S. N., de Beer, Z. W., & Green, R. J. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0632-6 · Cited by 8
Challenges of diagnosing and managing bronchiectasis in resource-limited settings: a case study
Adetiloye, A. O., Erhabor, G. E., Awopeju, O., Adewole, O., Onini, E., & Adewuya, O. A. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.32.82.18167 · Cited by 8
Lung microbiome: new insights into bronchiectasis’ outcome
Azoicai, A. N., Lupu, A., Alexoae, M. M., Stârcea, I. M., Mocanu, A., Lupu, V. V., Mitrofan, E. C., Nedelcu, A. H., Ţepordei, R. T., Munteanu, D., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1405399 · Cited by 7
Lung microbiota: a new hope for treating acute respiratory distress syndrome?
Tang, Y., Liu, B., Ma, A., Wang, B., Xiong, H., Zhou, Y., Yang, J. Y., & Kang, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1586949 · Cited by 8
The bronchiectasis microbiome: current understanding and treatment implications
Narayana, J. K., Aogáin, M. M., Hansbro, P. M., & Chotirmall, S. H. (2024) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001131 · Cited by 8
Cytokine responses to two common respiratory pathogens in children are dependent on interleukin-1β
Chen, A. C. –., Xi, Y., Carroll, M. L., Petsky, H., Gardiner, S. J., Pizzutto, S. J., Yerkovich, S. T., Baines, K. J., Gibson, P. G., Hodge, S. J., et al. (2017) · ERJ Open Research · doi:10.1183/23120541.00025-2017 · Cited by 7
Self-citation
Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trials
Weiser, R., Rye, P. D., & Mahenthiralingam, E. (2021) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2021.106133 · Cited by 7
Exploring factors associated with acquisition and chronicity of infection in bronchiectasis: A population-based study
Shkeiri, R., Saliba, W., Stein, N., Najjar‐Debbiny, R., Weber, R., Dror, S. K., Shaked‐Mishan, P., Adir, Y., & Shteinberg, M. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106487 · Cited by 6
Approaches to Sampling the Respiratory Microbiome
Dickson, R. P. (2022) · Respiratory medicine · doi:10.1007/978-3-030-87104-8_1 · Cited by 6
Continuous versus intermittent antibiotics for non-cystic fibrosis bronchiectasis
Donovan, T., Felix, L. M., Chalmers, J. D., Milan, S. J., Mathioudakis, A. G., & Spencer, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012733 · Cited by 6
Intermittent prophylactic antibiotics for bronchiectasis
Spencer, S., Donovan, T., Chalmers, J. D., Mathioudakis, A. G., McDonnell, M. J., Tsang, A., & Pilkington, G. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013254 · Cited by 6
Bacterial Pneumonia Alters the Respiratory Microbiota and Inflammatory Profile Via the Lung Microbiome-Immune Axis
Ye, X. Z., Shen, B., Cai, Z., Chen, D., & Wu, Y. (2025) · Current Microbiology · doi:10.1007/s00284-025-04482-w · Cited by 5
Microbiome in Chronic Lung Diseases
Mammen, M. J., & Sethi, S. (2017) · Barcelona Respiratory Network · doi:10.23866/brnrev:2017-m0042 · Cited by 5
Sampling the lung microbiome
Dickson, R. P., & Cox, M. J. (2019) · European Respiratory Society eBooks · doi:10.1183/2312508x.10015418 · Cited by 5
Non-cystic fibrosis bronchiectasis: The long road to multidrug resistant bacteria
Menéndez, R., Sahuquillo-Arce, J. M., Méndez, R., & Hernández-Cabezas, A. (2016) · Community Acquired Infection · doi:10.4103/2225-6482.198491 · Cited by 5
Bacteria of the lung microbiome and health biomarkers in chronic airway disease: a systematic review and meta-analysis
Grassi, L. C., Heye, F., Proesmans, K., Abatih, E., Daele, A. V., Lahousse, L., & Crabbé, A. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-00967-z · Cited by 4
Future directions: the next 10 years in research
Chotirmall, S. H. (2018) · European Respiratory Society eBooks · doi:10.1183/2312508x.10017217 · Cited by 5
Clinical and Lung Microbiome Impact of Chronic Versus Intermittent Pseudomonas aeruginosa Infection in Bronchiectasis
Fernández‐Barat, L., López-Aladid, R., Alcaraz-Serrano, V., Vázquez, N., Bueno, L., Pastor-Ibáñez, R., Lingren, L., Sanz-Fraile, H., Oscanoa, P., Motos, A., et al. (2025) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2025.03.003 · Cited by 4
Polymicrobial Biofilms in Cystic Fibrosis Lung Infections: Effects on Antimicrobial Susceptibility
Galdino, A. C. M., Vaillancourt, M., Celedonio, D., & Jorth, P. A. (2022) · Springer series on biofilms · doi:10.1007/978-3-031-15349-5_7 · Cited by 5
Bad company? The pericardium microbiome in people investigated for tuberculous pericarditis in an HIV-prevalent setting
Nyawo, G. R., Naidoo, C. C., Wu, B. G., Kwok, B., Clemente, J. C., Li, Y., Minnies, S., Reeve, B. W. P., Moodley, S., John, T.-J., et al. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105434 · Cited by 3
Clinical Relevance of Distinguishing Between Three Endoscopy-Based Conditions, Bronchiectasis, Bronchomalacia, and Their Combination in Dogs: A Retrospective Study
Lyssens, A., Bolen, G., Fastrès, A., Clercx, C., & Billen, F. (2025) · Veterinary Sciences · doi:10.3390/vetsci12050487 · Cited by 3
Comparison of Bronchoalveolar Lavage and Sputum Microbiology in Patients with Primary Ciliary Dyskinesia
Emiralioğlu, N., Sancak, B., Tuğcu, G. D., Şener, B., Yalçın, E., Doğru, D., Ki̇per, N., & Özçelik, U. (2017) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2016.0718 · Cited by 3
Short-term Tolerance to Inhaled Antibiotics in Patients With Bronchial Infection not Associated With Cystic Fibrosis
Máiz, L., Nieto, R., Durán, D., Máiz, J., Ruiz‐Calvo, G., Muriel, A., Barbero, E., Vélez‐Díaz‐Pallarés, M., & Morillo, R. (2025) · Open Respiratory Archives · doi:10.1016/j.opresp.2025.100460 · Cited by 3
Bronchiectasis in adults: epidemiology, assessment of severity and prognosis
Chalmers, J. D. (2015) · Current Pulmonology Reports · doi:10.1007/s13665-015-0120-x · Cited by 3
The Cystic Fibrosis Airway Microbiome and Pathogens
Janahi, I. A., & Rehman, A. (2017) · InTech eBooks · doi:10.5772/67846 · Cited by 3
Pseudomonas aeruginosa and Bronchiectasis
Soyza, A. D., & Winstanley, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-61452-6_12 · Cited by 3
The pharmacological treatment of bronchiectasis
Melani, A. S., Lanzarone, N., & Rottoli, P. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1421064 · Cited by 3
Understanding the clinical implications of the “non-classical” microbiome in chronic lung disease: a viewpoint
Taylor, S., Crabbé, A., Hoffman, L., Chalmers, J. D., & Rogers, G. B. (2024) · European Respiratory Journal · doi:10.1183/13993003.02281-2023 · Cited by 3
Self-citation
Chronic exposure to diesel engine exhaust and alteration of the airway bacteriome
Jiang, M., Yan, Y., Wang, T., Han, J., Wang, B., Li, Y., Tang, J., & Zheng, Y. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.117857 · Cited by 3
Inflammatory Phenotypes of Bronchiectasis
Koukaki, E., Papaiakovou, G., Klironomou, A., Theofani, E., Matthaiou, A. Μ., Liapikou, A., Anagnostopoulos, N., Stratakos, G. K., Bakakos, P., & Rovina, N. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15100499 · Cited by 2
Epidemiological insights into Haemophilus influenzae and Pseudomonas aeruginosa persistent colonization in non-cystic fibrosis bronchiectasis patients: a longitudinal and multicenter study
Cadenas-Jiménez, I., Camps-Massa, P., Gonçalves-Carvalho, F., Benaali-Bakkar, Y., Quero, S., Rodríguez-Pons, L., Antuori, A., Saiz-Escobedo, L., Calvo-Silveria, S., Oliver, A., et al. (2026) · Respiratory Research · doi:10.1186/s12931-026-03553-1 · Cited by 2
Bronchiectasis
Aogáin, M. M., Chalmers, J. D., & Chotirmall, S. H. (2022) · Respiratory medicine · doi:10.1007/978-3-030-87104-8_7 · Cited by 2
Personalized approaches to bronchiectasis
Moreno, R. M. G., Martínez-Vergara, A., & Martínez‐García, M. Á. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1882853 · Cited by 2
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
Serisier, D. J. (2014) · Clinical Investigation · doi:10.4155/cli.14.51 · Cited by 2
Self-citation
Disbiosis microbiana en las bronquiectasias y la fibrosis quística
Dicker, A., & Chalmers, J. D. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2016.11.018 · Cited by 2
Long-Term Inhaled Antibiotic Treatment in Bronchiectasis
Shteinberg, M., Johnson, C. B., & HAWORTH, C. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-61452-6_16 · Cited by 2
Impact of underlying cause of bronchiectasis on clinical outcome: A comparative study on CF and Non-CF bronchiectasis in Egyptian children
Basha, N. E. (2018) · Egyptian Pediatric Association Gazette · doi:10.1016/j.epag.2018.03.001 · Cited by 2
Pathophysiology, Immunology, and Histopathology of Bronchiectasis
Menéndez, R., & Sibila, O. (2017) · Springer eBooks · doi:10.1007/978-3-319-61452-6_5 · Cited by 2
Phenotypes and endotypes
Chalmers, J. D. (2018) · European Respiratory Society eBooks · doi:10.1183/2312508x.10017118 · Cited by 2
Haemophilus, Antibiotic Therapy and the Airway Microbiome in Chronic Obstructive PulmonarydiseasePreprint
Brill, S., James, P. L., Cuthbertson, L., Zhu, A., Lawley, T. D., Cookson, W., Cox, M. J., Wedzicha, J. A., & Moffatt, M. F. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/419127 · Cited by 2
Functional crosstalk between the lung and eye: a new frontier in chronic lung diseases
Lee, H., Taylor-Blair, H. C., Chellappan, D. K., Rubis, G. D., Paudel, K. R., Oliver, B. G. G., Dua, K., & Yeung, S. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04136-7 · Cited by 1
Proposed treatment algorithms for dogs with chronic bronchitis associated with irreversible airway changes: bronchiectasis and/or bronchomalacia
Lyssens, A., Roels, É., Clercx, C., & Billen, F. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1686007 · Cited by 1
Secondary antibody deficiencies: what’s around the corner?
Lagnese, G., Messuri, C., Poto, R., Varricchi, G., & Spadaro, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1672413 · Cited by 1
Differences in sputum microbiota based on cure status of patients with nontuberculous mycobacterial pulmonary disease
Kang, N., Kim, S., Kim, D. H., & Jhun, B. W. (2025) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2024.209 · Cited by 1
Insights into human respiratory microbiome under dysbiosis and its analysis tool
Helal, M., & Bari, V. K. (2025) · Frontiers in Microbiomes · doi:10.3389/frmbi.2025.1549166 · Cited by 1
Targeting Inflammation in Bronchiectasis
Aogáin, M. M., Gilmour, A., Chalmers, J. D., & Chotirmall, S. H. (2026) · Drugs · doi:10.1007/s40265-026-02314-0 · Cited by 1
Republished: Respiratory microbiota: addressing clinical questions, informing clinical practice
Rogers, G. B., Shaw, D. E., Marsh, R. L., Carroll, M. P., Serisier, D. J., & Bruce, K. D. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2014-205826rep · Cited by 1
Self-citation
The Role of Other Bacteria, Fungi, and Viruses in Bronchiectasis
O’Donnell, A. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-61452-6_13 · Cited by 1
The “-Omics” of the New Bronchopulmonary Dysplasia
Lal, C. V., Ambalavanan, N., & Bhandari, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54605-8.00004-0 · Cited by 1
Aerosolized Ampicillin in a Patient With Recurrent Respiratory Infections
Máiz, L., & Nieto, R. (2024) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2024.05.018 · Cited by 1

Authors: Rogers, G. B., Zain, N. M. M., Bruce, K. D., Burr, L. D., Chen, A. C., Rivett, D. W., McGuckin, M. A., & Serisier, D. J.
Affiliations: Translational Research Institute (AU)
King's College London (GB)
Imperial College London (GB)
Corresponding author: Rogers, Geraint B.
ORCID: Rogers, Geraint B.
Zain, Nur Masirah M.
Bruce, Kenneth D.
Burr, Lucy D.
Chen, Alice C.
Rivett, Damian W.
McGuckin, Michael A.
Serisier, David J.
Venue: Annals of the American Thoracic Society
Publisher: Oxford University Press (OUP)
Published: 2014-05-01
Volume: 11
Issue: 4
Pages: 496-503
ISSN: 2325-6621 (ISSN-L)
2329-6933
DOI: 10.1513/annalsats.201310-335oc
OpenAlex: W2119832209
Cited by: 244
References: 19
Citations by year: 2026: 10 · 2025: 18 · 2024: 16 · 2023: 11 · 2022: 21 · 2021: 17 · 2020: 16 · 2019: 23 · 2018: 33 · 2017: 29 · 2016: 15 · 2015: 23 · 2014: 12
FWCI: 21.14
Type: journal article
Language: en
Open access: closed
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: Annals of the American Thoracic Society (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords: non-cystic fibrosis bronchiectasis, airway microbiome, exacerbation prediction, Pseudomonas aeruginosa, Haemophilus influenzae, Veillonella, induced sputum, bacterial respiratory pathogens, C-reactive protein, sputum cytokines, interleukin-8, IL-1β, lung function
MeSH terms: Aged, Bronchiectasis, DNA, Bacterial, Female, Forced Expiratory Volume, Haemophilus Infections, Haemophilus influenzae, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Pseudomonas aeruginosa, Pseudomonas Infections, RNA, Ribosomal, 16S, Sputum, Cohort Studies, Disease Progression, Risk Assessment, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Novel Microbiota Stratification System Predicts Future Exacerbations in Bronchiectasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks